Combination of Paclitaxel and PXR Antagonist SPA70 Reverses Paclitaxel-Resistant Non-Small Cell Lung CancerXiaxia Niu, Hongmei Cui|Cells|2022Cited by 20
The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 MelanomaHongmei Cui, Wěi Li|Frontiers in Pharmacology|2021Cited by 12